Tag Archives: Segluromet

PBS lists new diabetes drug

A new treatment option is available for adult patients with Type 2 Diabetes. Steglatro (ertugliflozin), listed on the Pharmaceutical Benefits Scheme, is a new, SGLT2 inhibitor treatment option for Type 2 Diabetes Mellitus (T2DM). Steglatro provides healthcare care professionals with another option for patients that are currently on metformin +/- …

Read More »